Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients

BACKGROUND: Current treatment of acute leukemia is based on anthracycline chemotherapy. Anthracyclines, despite improving patient survival, have serious cardiotoxicity and therefore cardiac monitoring should be a priority. The purpose of this study is to explore the possible early predictors of anth...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xi, Weng, Yue, Jiang, Tiantian, Ou, Wenxin, Zhang, Nan, Dong, Qian, Tang, Xiaoqiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571315/
https://www.ncbi.nlm.nih.gov/pubmed/37833648
http://dx.doi.org/10.1186/s12885-023-11060-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571315/
https://www.ncbi.nlm.nih.gov/pubmed/37833648
http://dx.doi.org/10.1186/s12885-023-11060-5

Ejemplares similares